SGCA
GWPH

Steel Grove Capital Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Steel Grove Capital Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,271
Closed -$220K – 345
2018
Q3 		$220K Buy
+1,271
New +$183K 0.03% 286

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steel Grove Capital Advisors's GWPH Position: Q4 2018 in Review

Steel Grove Capital Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 1,271 shares — an estimated $220K sold.

Steel Grove Capital Advisors first reported a position in GWPH in Q3 2018 and held it in 1 quarter. The position peaked at $220K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • Steel Grove Capital Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Steel Grove Capital Advisors sold 1,271 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $220K.
  • Steel Grove Capital Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 1 quarter.
  • Steel Grove Capital Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $220K in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Steel Grove Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.